0000014272-14-000048.txt : 20140206 0000014272-14-000048.hdr.sgml : 20140206 20140206172853 ACCESSION NUMBER: 0000014272-14-000048 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140206 FILED AS OF DATE: 20140206 DATE AS OF CHANGE: 20140206 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Caldarella Joseph C CENTRAL INDEX KEY: 0001341069 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 14581144 MAIL ADDRESS: STREET 1: BRISTOL-MYERS SQUIBB COMPANY STREET 2: RT 206 & PROVINCELINE ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 wf-form4_139172572240390.xml FORM 4 X0306 4 2014-02-06 0 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001341069 Caldarella Joseph C BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 0 1 0 0 SVP & Controller Common Stock, $0.10 par value 2014-02-06 4 M 0 10900 22.14 A 79242 D Common Stock, $0.10 par value 2014-02-06 4 M 0 15584 17.51 A 94826 D Common Stock, $0.10 par value 2014-02-06 4 S 0 35471 48.8979 D 59355 D Option (right to buy) 22.14 2014-02-06 4 M 0 10900 0 D 2018-03-03 Common Stock, $0.10 par value 10900.0 0 D Option (right to buy) 17.51 2014-02-06 4 M 0 15584 0 D 2019-03-02 Common Stock, $0.10 par value 15584.0 35000 D The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $48.87 to $48.94, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 4, 2008. Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 3, 2009. /s/ Robert J. Wollin, attorney-in-fact for Joseph C. Caldarella 2014-02-06